Gelonghui August 29th | Yirui Biological (300942.SZ) released the semi-annual report for the year 2024, with a reported half-year revenue of 0.104 billion yuan, a 7.55% decrease year-on-year; the net income attributable to the shareholders of the listed company was -1.5595 million yuan, narrowing the loss year-on-year; the net income attributable to the shareholders of the listed company after deducting non-recurring gains and losses was -5.2591 million yuan; the basic earnings per share was -0.0039 yuan.
易瑞生物(300942.SZ)：上半年净亏损155.95万元
In the first half of the year, Yirui Biological (300942.SZ) reported a net loss of 1.5595 million yuan.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.